Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility where there are wide-spread medical needs.

Further reading »

Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »

The Share

Latest News

Oasmia Pharmaceutical AB Announces Commercial Launch of Paclical in Russia and CIS Countries

October 5 2015
First commercial shipment initiate the launch by Oasmia’s strategic partner Pharmasyntez to distribute the Company’s lead cancer product across the Russian Federation as well as the Commonwealth of Independent States
Further reading »

Communiqué from Oasmia’s Annual General Meeting 2015

September 30 2015
Oasmia Pharmaceutical AB (publ.), with VAT no SE556332-667601, held its Annual General Meeting for the fiscal year 2014/2015 on Monday, September 28, 2015, where and the following main resolutions were made. For detailed information about the content of the resolutions, see the complete notice for Annual General Meeting which is available on Oasmia’s website www.oasmia.com, together with the complete proposals for the resolutions below.
Further reading »

Oasmia Pharmaceutical AB Files Registration Statement on Form F-1/A for its Proposed Public Offering; Adds Warrants

September 28 2015
Further reading »